Metraipolis › archive › dc_c56edcc8d083

Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis — Europe PMC PMID:41663949

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41663949
DOI
10.1186/s12876-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-11-05T23:50:33.136Z
SHA-256 of the archived text
f4e094e1b93a0e692c690b85668a87f08434589e57d1f6923e5a91ddc1ae3159
Stable URL of this page
https://metraipolis.com/documento/dc_c56edcc8d083

How to cite

Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis — Europe PMC PMID:41663949 — Europe PMC (en), https://europepmc.org/article/MED/41663949 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c56edcc8d083 (Metraipolis archive dc_c56edcc8d083, sha256 f4e094e1b93a0e692c690b85668a87f08434589e57d1f6923e5a91ddc1ae3159)
BibTeX
@misc{dcc56edcc8d083,
  title = {Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis — Europe PMC PMID:41663949},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41663949},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c56edcc8d083; sha256 f4e094e1b93a0e692c690b85668a87f08434589e57d1f6923e5a91ddc1ae3159},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41663949. Agents can read the archived copy with the MCP tool read_document.